Streetbeat News

Analyst Ratings

AA

Goldman Sachs analyst Emily Chieng has maintained a 'Buy' rating on Alcoa (NYSE:AA) but lowered the price target from $54 to $46.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 2:32 pm

GPN

Barclays analyst Ramsey El-Assal maintains an Overweight rating on Global Payments (NYSE:GPN) and raises the price target from $125 to $135.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 2:32 pm

VEL

Citigroup analyst Arren Cyganovich has maintained a Neutral rating on Velocity Financial (NYSE:VEL) and raised the price target from $10 to $12.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 2:31 pm

FTV

Barclays analyst Julian Mitchell maintains an Overweight rating on Fortive (NYSE:FTV) and raises the price target from $72 to $77.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 2:31 pm

UAL

Citigroup analyst Stephen Trent has maintained a 'Buy' rating on United Airlines Holdings (NASDAQ:UAL) and raised the price target from $70 to $75.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 2:31 pm

ETN

Barclays analyst Julian Mitchell maintains an Underweight rating on Eaton Corp (NYSE:ETN) and raises the price target from $159 to $170.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 2:30 pm

C

SYF

Citigroup analyst Arren Cyganovich has reiterated a 'Buy' rating on Synchrony Financial (SYF) and maintained a price target of $43.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 2:30 pm

DISH

Barclays analyst Kannan Venkateshwar has maintained an Underweight rating on DISH Network and lowered the price target from $10 to $5.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 2:30 pm

BABA

BTGOF

GE

GM

GSK

HNHPF

IEP

JNJ

META

NVO

SIVBQ

UBS

Meta's Threads app has reached 100 million users in five days, making it the fastest-growing consumer application in history. Nanobiotix has entered a global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica, a unit of Johnson & Johnson, for the investigational radioenhancer NBTXR3. GSK's Arexvy vaccine for respiratory syncytial virus has been approved in the UK for older adults. BT Group's CEO Philip Jansen is stepping down within the next 12 months. Foxconn has withdrawn from a $19.5 billion semiconductor joint venture with Vedanta, impacting India's chipmaking plans. General Motors has reduced the starting price for the Cadillac Lyriq by 14% in China. SVB Financial Group is suing the U.S. Federal Deposit Insurance Corporation to recover $1.93 billion. Saudi National Bank's plan to increase its stake in UBS Group's Credit Suisse has been halted by Swiss regulator FINMA. Godrej Aerospace is planning to invest in General Electric's GE414 engine manufacturing operations. Carl Icahn has revised loan agreements and recovery strategy after a short-seller attack led to a 40% drop in Icahn Enterprises' shares. Novo Nordisk's weight-loss medications are under European investigation over suicidal risks. Alibaba's Youku is airing a series focusing on China's semiconductor leadership.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 2:30 pm

SSU

Citigroup analyst Ygal Arounian has downgraded SIGNA Sports United (NYSE:SSU) from Neutral to Sell and lowered the price target from $3.9 to $1.9.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 2:29 pm